Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.
Alternative lengthening of telomeres (ALT)
Cancer telomeres
Genomics
SK-MEL-2
Saos-2
Single molecule optical mapping
U2OS
Journal
BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258
Informations de publication
Date de publication:
15 Jul 2020
15 Jul 2020
Historique:
received:
12
05
2020
accepted:
08
07
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
19
3
2021
Statut:
epublish
Résumé
Telomeric DNA is typically comprised of G-rich tandem repeat motifs and maintained by telomerase (Greider CW, Blackburn EH; Cell 51:887-898; 1987). In eukaryotes lacking telomerase, a variety of DNA repair and DNA recombination based pathways for telomere maintenance have evolved in organisms normally dependent upon telomerase for telomere elongation (Webb CJ, Wu Y, Zakian VA; Cold Spring Harb Perspect Biol 5:a012666; 2013); collectively called Alternative Lengthening of Telomeres (ALT) pathways. By measuring (TTAGGG) n tract lengths from the same large DNA molecules that were optically mapped, we simultaneously analyzed telomere length dynamics and subtelomere-linked structural changes at a large number of specific subtelomeric loci in the ALT-positive cell lines U2OS, SK-MEL-2 and Saos-2. Our results revealed loci-specific ALT telomere features. For example, while each subtelomere included examples of single molecules with terminal (TTAGGG) n tracts as well as examples of recombinant telomeric single molecules, the ratio of these molecules was subtelomere-specific, ranging from 33:1 (19p) to 1:25 (19q) in U2OS. The Saos-2 cell line shows a similar percentage of recombinant telomeres. The frequency of recombinant subtelomeres of SK-MEL-2 (11%) is about half that of U2OS and Saos-2 (24 and 19% respectively). Terminal (TTAGGG) n tract lengths and heterogeneity levels, the frequencies of telomere signal-free ends, and the frequency and size of retained internal telomere-like sequences (ITSs) at recombinant telomere fusion junctions all varied according to the specific subtelomere involved in a particular cell line. Very large linear extrachromosomal telomere repeat (ECTR) DNA molecules were found in all three cell lines; these are in principle capable of templating synthesis of new long telomere tracts via break-induced repair (BIR) long-tract DNA synthesis mechanisms and contributing to the very long telomere tract length and heterogeneity characteristic of ALT cells. Many of longest telomere tracts (both end-telomeres and linear ECTRs) displayed punctate CRISPR/Cas9-dependent (TTAGGG) n labeling patterns indicative of interspersion of stretches of non-canonical telomere repeats. Identifying individual subtelomeres and characterizing linked telomere (TTAGGG) n tract lengths and structural changes using our new single-molecule methodologies reveals the structural consequences of telomere damage, repair and recombination mechanisms in human ALT cells in unprecedented molecular detail and significant differences in different ALT-positive cell lines.
Sections du résumé
BACKGROUND
BACKGROUND
Telomeric DNA is typically comprised of G-rich tandem repeat motifs and maintained by telomerase (Greider CW, Blackburn EH; Cell 51:887-898; 1987). In eukaryotes lacking telomerase, a variety of DNA repair and DNA recombination based pathways for telomere maintenance have evolved in organisms normally dependent upon telomerase for telomere elongation (Webb CJ, Wu Y, Zakian VA; Cold Spring Harb Perspect Biol 5:a012666; 2013); collectively called Alternative Lengthening of Telomeres (ALT) pathways. By measuring (TTAGGG) n tract lengths from the same large DNA molecules that were optically mapped, we simultaneously analyzed telomere length dynamics and subtelomere-linked structural changes at a large number of specific subtelomeric loci in the ALT-positive cell lines U2OS, SK-MEL-2 and Saos-2.
RESULTS
RESULTS
Our results revealed loci-specific ALT telomere features. For example, while each subtelomere included examples of single molecules with terminal (TTAGGG) n tracts as well as examples of recombinant telomeric single molecules, the ratio of these molecules was subtelomere-specific, ranging from 33:1 (19p) to 1:25 (19q) in U2OS. The Saos-2 cell line shows a similar percentage of recombinant telomeres. The frequency of recombinant subtelomeres of SK-MEL-2 (11%) is about half that of U2OS and Saos-2 (24 and 19% respectively). Terminal (TTAGGG) n tract lengths and heterogeneity levels, the frequencies of telomere signal-free ends, and the frequency and size of retained internal telomere-like sequences (ITSs) at recombinant telomere fusion junctions all varied according to the specific subtelomere involved in a particular cell line. Very large linear extrachromosomal telomere repeat (ECTR) DNA molecules were found in all three cell lines; these are in principle capable of templating synthesis of new long telomere tracts via break-induced repair (BIR) long-tract DNA synthesis mechanisms and contributing to the very long telomere tract length and heterogeneity characteristic of ALT cells. Many of longest telomere tracts (both end-telomeres and linear ECTRs) displayed punctate CRISPR/Cas9-dependent (TTAGGG) n labeling patterns indicative of interspersion of stretches of non-canonical telomere repeats.
CONCLUSION
CONCLUSIONS
Identifying individual subtelomeres and characterizing linked telomere (TTAGGG) n tract lengths and structural changes using our new single-molecule methodologies reveals the structural consequences of telomere damage, repair and recombination mechanisms in human ALT cells in unprecedented molecular detail and significant differences in different ALT-positive cell lines.
Identifiants
pubmed: 32669102
doi: 10.1186/s12864-020-06901-7
pii: 10.1186/s12864-020-06901-7
pmc: PMC7364475
doi:
Substances chimiques
DNA
9007-49-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
485Subventions
Organisme : NHGRI NIH HHS
ID : R01 HG005946
Pays : United States
Organisme : NIH HHS
ID : R21HG007205 and R21CA177395
Pays : United States
Références
Bioessays. 2008 Jan;30(1):25-37
pubmed: 18081009
Cell. 2015 Feb 26;160(5):913-927
pubmed: 25723166
Cell. 2017 Jun 29;170(1):86-101.e16
pubmed: 28666128
Cancer Res. 2007 Aug 1;67(15):7072-7
pubmed: 17652140
Cancer Res. 2005 Apr 1;65(7):2730-7
pubmed: 15805272
Genome Res. 2017 Nov;27(11):1904-1915
pubmed: 29025896
Int J Urol. 1997 Jul;4(4):407-10
pubmed: 9256332
Nat Commun. 2017 Jan 24;8:14015
pubmed: 28117327
Genes Dev. 2015 Feb 1;29(3):322-36
pubmed: 25644606
EMBO Rep. 2011 Dec 23;13(1):52-9
pubmed: 22157895
Nat Biotechnol. 2012 Aug;30(8):771-6
pubmed: 22797562
Aging (Albany NY). 2012 Jun;4(6):379-92
pubmed: 22683684
Science. 1994 Dec 23;266(5193):2011-5
pubmed: 7605428
Neoplasia. 2013 Nov;15(11):1301-13
pubmed: 24339742
EMBO Rep. 2017 Jun;18(6):929-946
pubmed: 28500257
Nat Commun. 2019 Mar 4;10(1):1025
pubmed: 30833565
PLoS Genet. 2012;8(7):e1002772
pubmed: 22829774
Nat Genet. 2000 Dec;26(4):447-50
pubmed: 11101843
J Cell Biol. 2012 Dec 10;199(6):893-906
pubmed: 23229897
EMBO Rep. 2016 Dec;17(12):1731-1737
pubmed: 27760777
Ann Anat. 2010 Sep 20;192(5):284-91
pubmed: 20732797
Nature. 2000 Aug 10;406(6796):641-5
pubmed: 10949306
Science. 2012 May 4;336(6081):593-7
pubmed: 22556254
EMBO Rep. 2017 Jun;18(6):914-928
pubmed: 28487353
Cell. 2010 Apr 2;141(1):81-93
pubmed: 20371347
Nat Struct Mol Biol. 2015 Nov;22(11):875-80
pubmed: 26581522
Nucleic Acids Res. 2017 May 19;45(9):e73
pubmed: 28180280
Science. 2017 Feb 10;355(6325):638-641
pubmed: 28082411
Cell. 2009 Jul 10;138(1):90-103
pubmed: 19596237
Nat Rev Genet. 2010 May;11(5):319-30
pubmed: 20351727
Genes Dev. 2010 Apr 1;24(7):720-33
pubmed: 20360388
Nat Biotechnol. 2009 Dec;27(12):1181-5
pubmed: 19935656
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1758-61
pubmed: 2308935
Nature. 2016 Nov 3;539(7627):54-58
pubmed: 27760120
PLoS Genet. 2020 Jan 27;16(1):e1008347
pubmed: 31986135
Nat Commun. 2014 Oct 21;5:5220
pubmed: 25330849
Science. 2015 Jan 16;347(6219):273-7
pubmed: 25593184
Cell. 1987 Dec 24;51(6):887-98
pubmed: 3319189
EMBO J. 2017 Oct 2;36(19):2907-2919
pubmed: 28877996
Mob Genet Elements. 2011 Jul;1(2):128-134
pubmed: 22016861
Trends Genet. 2017 Dec;33(12):921-932
pubmed: 28969871
EMBO J. 2007 Jun 6;26(11):2707-18
pubmed: 17491589
Nat Rev Mol Cell Biol. 2017 Mar;18(3):175-186
pubmed: 28096526
Genetics. 2016 Jan;202(1):351-62
pubmed: 26510793
Mutat Res. 2012 Feb 1;730(1-2):59-67
pubmed: 21663926
Cell. 2014 Sep 25;159(1):108-121
pubmed: 25259924
Mol Cell. 2007 Oct 26;28(2):315-27
pubmed: 17964269
Cold Spring Harb Perspect Biol. 2013 Jun 01;5(6):
pubmed: 23732473